EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches

Xianpeng Zhou, Hao Wang, Biao Yan, Xinwen Nie, Qingjie Chen, Xiaosong Yang, Min Lei, Xiying Guo, Changhan Ouyang, Zhanhong Ren

Cardiovascular Drugs and Therapy · 2025-12 · 39 (6) · 1521-1548

DOI: 10.1007/s10557-024-07642-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 06.12.2024. Verfasst von Xianpeng Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hubei University of Science and Technology, Xianning, 437100, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Ferroptosis, Cardiovascular Diseases, Cardiovascular Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 277 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Hubei University of Science and Technology School-level Fund, Scientific Research and Innovation Team of Hubei University of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Cardiovascular diseases (CVDs) are major public health problems that threaten the lives and health of individuals. The article has reviewed recent progresses about ferroptosis and ferroptosis-related intervention approaches for the treatment of CVDs and provided more references and strategies for targeting ferroptosis to prevent and treat CVDs. METHODS: A comprehensive review was conducted using the literature researches. RESULTS AND DISCUSSION: Many ferroptosis-targeted compounds and ferroptosis-related genes may be prospective targets for treating CVDs and our review provides a solid foundation for further studies about the detailed pathological mechanisms of CVDs. CONCLUSION: There are challenges and limitations about the translation of ferroptosis-targeted potential therapies from experimental research to clinical practice. It warrants further exploration to pursure safer and more effective ferroptosis-targeted thereapeutic approaches for CVDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCardiovascular DiseasesCardiovascular AgentsHumansAnimalsSignal TransductionMolecular Targeted Therapy

Stichwörter der Autor:innen

Amino acid metabolismCardiovascular diseasesFerroptosisIron metabolismLipid metabolism

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • Hubei University of Science and Technology, Xianning, 437100, Hubei, People's Republic of China.
  • Hubei University of Science and Technology, Xianning, 437100, Hubei, People's Republic of China. renzhanhong@hbust.edu.cn.

Förderung

  • Natural Science Foundation of Hubei Province
  • Hubei University of Science and Technology School-level Fund
  • Scientific Research and Innovation Team of Hubei University of Science and Technology
  • Special Project on Diabetes and Angiopathy

Zitieren

APA

Zhou, X., Wang, H., Yan, B., Nie, X., Chen, Q., Yang, X., Lei, M., Guo, X., Ouyang, C., & Ren, Z. (2025). Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches. Cardiovascular Drugs and Therapy, 39(6), 1521-1548. https://doi.org/10.1007/s10557-024-07642-5

Vancouver

Zhou X, Wang H, Yan B, Nie X, Chen Q, Yang X, et al. Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches. Cardiovascular Drugs and Therapy. 2025;39(6):1521-1548. doi:10.1007/s10557-024-07642-5

BibTeX
@article{Zhou2025,
  author = {Zhou, Xianpeng and Wang, Hao and Yan, Biao and Nie, Xinwen and Chen, Qingjie and Yang, Xiaosong and Lei, Min and Guo, Xiying and Ouyang, Changhan and Ren, Zhanhong},
  title = {Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  volume = {39},
  number = {6},
  pages = {1521--1548},
  doi = {10.1007/s10557-024-07642-5}
}
Kostenlos starten →